Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Discovery
61 Articles Available
1
3
Can't find what you're looking for? Try our
advanced search
.
Virus
New Insights into Virus Evasion Tactics
PAO-M00-19-NI-003
Research
Researchers Discover Potential Cause for Alzheimer’s Disease
PAO-M11-18-NI-028
Research
Newfound Mechanism May Yield Ways to Counter Mistaken Immune Attack on Body
PR-M11-18-NI-097
Clinical Data
Aerie Pharmaceuticals Reports Topline Result from Rhopressa® Mechanism of Action Study
PR-M09-18-NI-034
CRISPR
CRISPR is Helping Dogs with Muscular Dystrophy and Young Boys Could be Next
PAO-M08-18-NI-030
Clinical Data
Novartis Reports Promising Results for its New Alpha Specific PI3K Inhibitor BYL719
PAO-M08-18-NI-028
FDA Approval
AbbVie Receives FDA Approval for IMBRUVICA® Plus Rituximab as a Blood Cancer Treatment
PAO-M08-18-NI-027
Research
A Key to the Cage: Opening the Living Membrane Gate
PR-M06-18-NI-066
GMP
State-of-the-Art Biologics Manufacturing in an Unexpected Location
PAP-Q2-18-CL-010
Next-Generation Drug Development
Challenges for Next-Generation Biological Therapeutics Discovery and Development
PAP-Q2-18-FA-001
Fill-Finish Services
Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services
PAP-Q2-18-CL-020
Drug Discovery
TEVA Hopes to Launch New Migraine Drug Immediately After PDUFA Date
PAO-M05-18-NI-020
Discovery
A New Landscape: M&A in the Discovery & Research Sector
PAP-Q1-18-NI-002
Biologics
Fully Supporting Customer Needs for Biologics Development and Manufacturing
PAP-Q1-18-CL-016
Innovation
Single-Pill, HIV-1 Combination Therapy Approved
PAO-M11-17-NI-050
Discovery
Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration
PAO-M11-17-NI-049
FDA Approval
Advanced Follicular Lymphoma Treatment Approved
PAO-M11-17-NI-048
Gene Editing
Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems
PAO-M11-17-NI-046
Non-Opioid
SiteOne Therapeutics Garners US Department of Defense Award
PAO-M11-17-NI-036
Acquisition
Mallinckrodt Expands Pipeline with Ocera Therapeutics Buy
PAO-M11-17-NI-020
CRISPR
CRISPR Technology Could Enable New Treatments for Resistant Fungal Infections
PAO-M11-17-NI-006
Genetics
Unlocking the Relationship Between Genetics and Disease
PAO-M10-17-NI-044
Drug Discovery
Forge Therapeutics and Evotec Expand Their Partnership
PAO-M10-17-NI-041
Research
Don’t Be Scared: New Insight into How the Brain Learns Fear
PAO-M10-17-NI-040
1
3
»
